ARTL

Artelo Biosciences Inc. (ARTL), headquartered in La Jolla, California, is a clinical-stage biopharmaceutical firm focused on developing innovative therapies that utilize the endocannabinoid system to tackle a range of medical challenges. The company aims to enhance cannabinoid efficacy through its diverse pipeline, which primarily targets oncology, pain management, and appetite stimulation. With a commitment to scientific rigor and compliance with regulatory standards, Artelo is poised to address significant unmet needs in the cannabinoid therapeutics sector, presenting a compelling opportunity for institutional investors seeking growth in the biopharmaceutical space.